Patents/Assignees

Redhill Biopharma Ltd.

11 patents in portfolio

US12569475utility2026
Method for Eradicating Helicobacter Pylori Infection in Patients Regardless of Body Mass Index
0 cites
US12551469utility2026
Sphingosine Kinase 2 Inhibitor for Treating Coronavirus Infection
0 cites
US12502381utility2025
Serine Protease Inhibitor for Treating Coronavirus Infection
0 cites
US12370206utility2025
Therapy for Inhibition of Single-stranded RNA Virus Replication
0 cites
US12115150utility2024
Biomarkers of Coronavirus Pneumonia
0 cites
US11931463utility2024
All-in-one Fixed-dose Combination for Treating Helicobacter Pylori Infection
0 cites
US11918560utility2024
Serine Protease Inhibitor for Treating Coronavirus Infection
0 cites
US11878011utility2024
Method for Eradicating Helicobacter Pylori Infection in Patients Regardless of Body Mass Index
0 cites
US11786541utility2023
Inhibitor of Sphingosine Kinase 2 for Treating Ebola
0 cites
US11633385utility2023
Combination Compositions for Treatment of Cancer
0 cites
US11590154utility2023
Triple Antibiotic Fixed-dose Combination Products, Dosing Regimen, Methods, and Kits for Treating Pulmonary Non-tuberculosis Mycobacterial Infections
0 cites